Reply

Affiliations

Comment

Christina L Marcaccio et al. J Vasc Surg. 2022 Jul.

. 2022 Jul;76(1):309.

doi: 10.1016/j.jvs.2022.03.003.

¹ Department of Surgery, Division of Vascular and Endovascular Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.

No abstract available

Comment on

Efficacy and safety of perioperative dual antiplatelet therapy with ticagrelor versus clopidogrel in carotid artery stenting.
Marcaccio CL, Patel PB, Liang P, Rastogi V, Stangenberg L, Jim J, Schneider PA, Schermerhorn ML. Marcaccio CL, et al. J Vasc Surg. 2022 Apr;75(4):1293-1303.e8. doi: 10.1016/j.jvs.2021.09.045. Epub 2021 Oct 13. J Vasc Surg. 2022. PMID: 34655685 Free PMC article.
Ticagrelor or clopidogrel for dual antiplatelet therapy after transcarotid and transfemoral stenting of the carotid artery: are we ready for a randomized controlled trial?
D'Oria M, Lepidi S. D'Oria M, et al. J Vasc Surg. 2022 Jul;76(1):307-309. doi: 10.1016/j.jvs.2022.02.060. J Vasc Surg. 2022. PMID: 35738790 No abstract available.